Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.
D001241:Aspirin / Q000627:therapeutic use*; D004176:Dipyridamole / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D008297:Male; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use*; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count; D011087:Polycythemia Vera / Q000150:complications / Q000628:therapy*; D013927:Thrombosis / Q000150:complications
D010761:Phosphorus Radioisotopes; D004176:Dipyridamole; D001241:Aspirin